University of Minnesota researchers have developed a new drug that holds the answer to defeating pancreatic cancer, finds study published in the journal iScience Translational Medicine/i. The study is based on successful outcomes in a mouse model - results researchers expect to carry over to human patients when the drug potentially begins human trials in 2013. The drug, Minnelide, is a type of injectable chemotherapy designed to target tumor cells. The drug ...
via Medindia Health News More READ
No comments:
Post a Comment